Effectiveness of 8 Week Multicomponent Exercise Program in Older Adults With Frailty and Cognitive Impairment

Launched by UNIVERSITY OF MALAGA · May 31, 2024

Keywords

ClinConnect Summary

This clinical trial is looking at how an 8-week exercise program can help older adults who are experiencing frailty and some level of cognitive impairment. The goal is to see if this exercise routine can improve various aspects of daily life, such as physical fitness, balance, strength in the arms, quality of life, independence, mental sharpness, and mood.

To be eligible for the study, participants need to be at least 65 years old, show signs of frailty based on a specific test, and be able to walk, either on their own or with assistance. They should also score 15 or higher on a cognitive exam that measures mental abilities. This study is open to all genders, and those who are committed to participating and can provide consent are encouraged to join. Participants can expect to engage in a structured exercise program and be monitored for changes in their health and well-being over the course of the study.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Adults over 65 years of age.
• • People with frailty according to the Short Physical Performance Battery,
• • who have the ability to walk (autonomous or with external aids),
• • and who obtain a score greater than or equal to 15 in the Lobo Mini Cognitive Examination (MEC-35 of Lobo).
• • patients with a resolved hip fracture, with Parkinson's,
• • Patients who are committed and motivated to carry out the study, as well as patients who agree to sign the informed consent and the report sheet prior to carrying out the study.
• Exclusion Criteria:
• • Old Adults under 65 years of age.
• • Patients who do not present frailty or the ability to walk (autonomous or with external aids).
• • People who obtain a score of less than 15 in the Lobo Mini Cognitive Exam therefore presenting a serious deterioration of the emotional and cognitive state.
• • Older adults who are under treatment with tranquilizers or sedatives, non-diuretic hypotensive agents or antidepressants.
• • Patients with amyotrophic lateral sclerosis, multiple sclerosis, diabetic neuropathy, severe sensory deficit, and study subjects without motivation or interest in participating in the study.
• • Older adults who do not agree to sign the study, will also be excluded from the study. informed consent and the report sheet prior to carrying out the study

Trial Officials